Anticancer Drug Metabolism: Chemotherapy Resistance and New Therapeutic Approaches

Part of book or chapter of book English OPEN
Akhdar, Hanane; Legendre, Claire; Aninat, Caroline; More, Fabrice;
(2012)
  • Publisher: InTech
  • References (218)
    218 references, page 1 of 22

    Aas, T., Borresen, A.L., Geisler, S., Smith-Sorensen, B., Johnsen, H., Varhaug, J.E., Akslen, L.A., and Lonning, P.E. (1996). Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med, Vol.2, No.7, 811-814.

    Adler, V., Yin, Z., Fuchs, S.Y., Benezra, M., Rosario, L., Tew, K.D., Pincus, M.R., Sardana, M., Henderson, C.J., Wolf, C.R., Davis, R.J., and Ronai, Z. (1999). Regulation of JNK signaling by GSTp. EMBO J, Vol.18, No.5, 1321-1334.

    Akhdar, H., Loyer, P., Rauch, C., Corlu, A., Guillouzo, A., and Morel, F. (2009). Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells. Eur J Cancer, Vol.45, No.12, 2219-2227.

    Andrei, D., Maciag, A.E., Chakrapani, H., Citro, M.L., Keefer, L.K., and Saavedra, J.E. (2008). Aryl bis(diazeniumdiolates): potent inducers of S-glutathionylation of cellular proteins and their in vitro antiproliferative activities. J Med Chem, Vol.51, No.24, 7944-7952.

    Baird, L., and Dinkova-Kostova, A.T. (2011). The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol, Vol.85, No.4, 241-272.

    Ban, N., Takahashi, Y., Takayama, T., Kura, T., Katahira, T., Sakamaki, S., and Niitsu, Y. (1996). Transfection of glutathione S-transferase (GST)-pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide. Cancer Res, Vol.56, No.15, 3577-3582.

    Baskin-Bey, E.S., Huang, W., Ishimura, N., Isomoto, H., Bronk, S.F., Braley, K., Craig, R.W., Moore, D.D., and Gores, G.J. (2006). Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins. Hepatology, Vol.44, No.1, 252-262.

    Basseville, A., Preisser, L., de Carne Trecesson, S., Boisdron-Celle, M., Gamelin, E., Coqueret, O., and Morel, A. (2011). Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells. Mol Cancer, Vol.10, No.1, 80.

    Bauer, B., Hartz, A.M., Fricker, G., and Miller, D.S. (2004). Pregnane X receptor upregulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol, Vol.66, No.3, 413-419.

    Baumert, C., and Hilgeroth, A. (2009). Recent advances in the development of P-gp inhibitors. Anticancer Agents Med Chem, Vol.9, No.4, 415-436.

  • Metrics
Share - Bookmark

  • Download from
    InTech via InTech (Part of book or chapter of book, 2012)
  • Cite this publication